The estimated Net Worth of Ann Scott Blouin is at least $3.49 Million dollars as of 7 May 2024. Ann Blouin owns over 350 units of Ensign Inc stock worth over $3,011,301 and over the last 6 years he sold ENSG stock worth over $163,948. In addition, he makes $311,771 as Independent Director at Ensign Inc.
Sign up
Ann Blouin ENSG stock SEC Form 4 insiders trading
Ann has made over 6 trades of the Ensign Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 350 units of ENSG stock worth $40,765 on 7 May 2024.
The largest trade he's ever made was selling 433 units of Ensign Inc stock on 20 December 2021 worth over $33,358. On average, Ann trades about 62 units every 31 days since 2019. As of 7 May 2024 he still owns at least 20,002 units of Ensign Inc stock.
You can see the complete history of Ann Blouin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ann Blouin biography
Dr. Ann S. Blouin Ph.D serves as Independent Director of the Company. Dr. Blouin has served as a member of our Board since November 2018. Dr. Blouin recently retired from her position as Executive Vice President of Customer Relations and previous position as Executive Vice President of Accreditation and Certification Operations at The Joint Commission where she provided leadership in aligning the strategic and operating goals of the organization with its client base. With more than 30 years of health care administration, consulting and clinical nursing experience, Dr. Blouin has held key senior leadership positions at community teaching hospitals and academic medical centers. While serving in key leadership roles with the consulting firms of Deloitte & Touche, LLP, Ernst & Young Global Limited, Cap Gemini SE and Huron Consulting Group, she worked with multiple health systems across the United States and Canada to help them improve operating cost efficiency and effectiveness, revenue management, care coordination, and quality and patient safety. Dr. Blouin is currently serving as President of PSQ Advisory, working with boards and senior leadership to deliver strategic guidance on patient care quality and safety America's health systems. In addition, Dr. Blouin also serves on the Institute for Healthcare Improvement Board of Directors and as an editorial advisor for the Journal of Nursing Administration. Dr. Blouin is an Assistant Professor at Loyola University of Chicago. Dr. Blouin earned her Doctor of Philosophy (PhD) in Nursing Sciences and Master Degree in Business Administration (MBA) from the University of Illinois at Chicago. Dr. Blouin received her Master of Science in Nursing (MSN) from Loyola University of Chicago, and Bachelor of Science in Nursing (BSN) from Lewis University in Romeoville, Illinois. Blouin’s extensive experience and leadership supports the conclusion that she should serve as one of our directors.
What is the salary of Ann Blouin?
As the Independent Director of Ensign Inc, the total compensation of Ann Blouin at Ensign Inc is $311,771. There are 10 executives at Ensign Inc getting paid more, with Christopher Christensen having the highest compensation of $6,311,710.
How old is Ann Blouin?
Ann Blouin is 67, he's been the Independent Director of Ensign Inc since 2018. There are 2 older and 14 younger executives at Ensign Inc. The oldest executive at Ensign Group Inc is Roy Edgar Christensen, 87, who is the Co-Founder & Chairman Emeritus.
What's Ann Blouin's mailing address?
Ann's mailing address filed with the SEC is 29222 RANCHO VIEJO ROAD, SUITE 127, SAN JUAN CAPISTRANO, CA, 92675.
Insiders trading at Ensign Inc
Over the last 17 years, insiders at Ensign Inc have traded over $6,325,963,448 worth of Ensign Inc stock and bought 34,766 units worth $1,074,633 . The most active insiders traders include Christopher R. Christensen, Roy E Christensen und Gregory K. Stapley. On average, Ensign Inc executives and independent directors trade stock every 12 days with the average trade being worth of $1,528,233. The most recent stock trade was executed by Barry Port on 29 August 2024, trading 5,618 units of ENSG stock currently worth $111,967.
What does Ensign Inc's logo look like?
Complete history of Ann Blouin stock trades at Ensign Inc
Ensign Inc executives and stock owners
Ensign Inc executives and other stock owners filed with the SEC include:
-
Christopher Christensen,
Co-Founder, Executive Chairman and the Chairman of the Board -
Barry Port,
Chief Executive Officer, Director -
Suzanne Snapper,
Chief Financial Officer, Executive Vice President -
Barry R. Port,
Pres, CEO & Director -
Suzanne D. Snapper,
CFO, Exec. VP & Director -
Chad Keetch,
Executive Vice President, Chief Investment Officer, Secretary -
Spencer W. Burton,
Pres & COO of Ensign Services, Inc. -
Spencer Burton,
President, Chief Operating Officer -
Chad A. Keetch,
Chief Investment Officer, Exec. VP & Sec. -
Daren Shaw,
Independent Director -
Lee Daniels,
Independent Director -
Ann Blouin,
Independent Director -
Barry Smith,
Independent Director -
Roy Edgar Christensen,
Co-Founder & Chairman Emeritus -
Roy Christensen,
Chairman Emeritus -
Swati Abbott,
Independent Director -
Kevin Reese,
Pres of Keystone Healthcare Inc -
Beverly B. Wittekind,
VP & Gen. Counsel -
Antoinette T. Hubenette,
Director -
John G. Nackel,
-
Family Trust Dated 10/24/05...,
10% owner -
Malene Davis,
Director -
Covey C. Christensen,
President of a subsidiary -
Clayton M Christensen,
Director -
Gregory K. Stapley,
V.P. & General Counsel -
Van R Johnson,
Director -
Thomas A Maloof,
Director -
Roy E Christensen Carol M.C...,
Chairman of the Board -
Family Trust Dated 8/17/92 ...,
Chairman of the Board -
Cory Monette,
President of a subsidiary -
Roy E Christensen Family Tr...,
Chairman of the Board -
John Albrechtsen,
President of a subsidiary -
Michael Dalton,
President of a subsidiary -
David M. Sedgwick,
V.P. of Org. Dev. -
Group Investments, L.L.C. E...,
10% owner -
Christopher R.Christensen F...,
President & CEO -
Charles M Blalack,
Director -
Alan Norman,
Chief Financial Officer -
Beverly B. Wittekind,
VP and General Counsel -
John O Agwunobi,
Director